The tumor-microenvironment-associated prognostic gene TIGIT promotes malignant phenotypes in esophageal carcinoma. [PDF]
Wang W +7 more
europepmc +1 more source
Apremilast combined with low-dose corticosteroids for lichenoid drug eruption following programmed cell death protein 1 inhibitor and lenvatinib therapy: A case report. [PDF]
Meng X, Li D, Zhou B, Liu J, Xu Y.
europepmc +1 more source
Editorial: Host-pathogen interactions: cellular damage, death, and adaptation in microbial infections. [PDF]
Verma C +4 more
europepmc +1 more source
Is PD-1/PD-L1 inhibitor plus bevacizumab superior to sorafenib as first-line treatment for advanced hepatocellular carcinoma? A pooled analysis of four phase 3 RCTs. [PDF]
Zhong Q, Li H, Hu W, Li Z, Hu Z.
europepmc +1 more source
A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma. [PDF]
Hu M +17 more
europepmc +1 more source
Programmed Death-Ligand 1 Expression Predicts Poor Prognosis in Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy. [PDF]
Park J +5 more
europepmc +1 more source
Targeting Inflammatory Cell Death: A Strategy for Discogenic Pain Relief. [PDF]
Wang L +12 more
europepmc +1 more source
Elucidating shared genes and pathways in programmed cell death with necrotizing enterocolitis: insights into novel therapeutic targets and glutathione. [PDF]
Zou P +15 more
europepmc +1 more source

